Ads
related to: Atopic Dermatitis Treatment- Start Saving On Your Rx
Download A $0 Copay Savings
Card For Your Rx. Terms Apply.
- Activate Your Copay Card
Activate Your Copay Savings Card
For Your Rx. Terms Apply
- Safety Information
Learn About Important Safety
Info For An FDA-Approved Rx
- Prescribing Information
Learn About An FDA-Approved Rx For
Moderate-To-Severe Eczema.
- Tell Us Your Story
Patients Can Share Their Experience
About Taking This Rx Eczema Pill.
- Rx Option For Teens 12-17
Learn About An Eczema Rx Option
For Patients 12 Years & Older
- Start Saving On Your Rx
Search results
Tapinarof Cream Effective For AD, Down to Age 2 Years
Medscape· 3 days agoResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.
Rapid Rx Quiz: New Agents for Treating Atopic Dermatitis
Medscape· 3 days agoTopical corticosteroids were the initial treatment option for atopic dermatitis (AD) beginning in...
J&J to acquire experimental eczema drug for $1.25B
NJBIZ· 1 day agoJohnson & Johnson plans to pay $1.25 billion for the rights to an experimental eczema treatment. The New Brunswick-based pharma giant announced the...
...Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for...
Morningstar· 3 days agoYJT comprises all assets relating to NM26, an investigational first-in-class bi-specific antibody for the treatment of atopic dermatitis
The 2024 Millionaire's Club: 3 Penny Stocks to Buy Now
InvestorPlace· 7 hours agoOne of the best ways to spot opportunities in penny stocks to buy is by following insiders. After...
J&J acquires experimental skin disorder drug for $1.25 billion
Reuters via AOL· 3 days agoJ&J will acquire a unit of Numab, backed by the parent of Danish drugmaker Novo Nordisk, to gain...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days ago- New study follows completion of first-in-human Phase 1b trial in atopic dermatitis patients, in which selectION observed safety and tolerability of si ...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 7 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Dupilumab: Future Treatment for Pediatric Alopecia Areata?
Medscape· 3 days agoChildren with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 7 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...